Suchergebnisse - "Tabarsi, Payam"

PubPharm (5)

1

Immunogenicity and safety of SpikoGen®, an adjuvanted recombinant SARS-CoV-2 spike protein vaccine as a homologous and heterologous booster vaccination : A randomized placebo-controlled trial

enthalten in: Immunology | 2022

von Tabarsi, P. | Anjidani, N. | Shahpari, R. | +5

2

Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine : a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022

von Tabarsi, P. | Anjidani, N. | Shahpari, R. | +9

3

Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran : findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adults

enthalten in: BMJ open | 2022

von Mohraz, M. | Salehi, M. | Tabarsi, P. | +13

ErratumIn: BMJ Open. 2022 Nov 7;12(11):e056872corr1. - PMID 36344009

4

No clinical benefit of high dose corticosteroid administration in patients with COVID-19 : A preliminary report of a randomized clinical trial

enthalten in: European journal of pharmacology | 2021

von Jamaati, H. | Hashemian, S. | Farzanegan, B. | +15

5

Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases : A randomized controlled trial

enthalten in: International immunopharmacology | 2021

von Tabarsi, P. | Barati, S. | Jamaati, H. | +11

1
[1]